LONDON, ONTARIO--(Marketwire - August 13, 2008) - Sernova Corp. (TSX VENTURE: SVA) - Sernova Corp.'s Sertolin technology is being highlighted at the International Congress of The Transplantation Society (TTS) in Sydney, Australia this week, and was also featured on CTV’s National News on Sunday night, with the message that Canadian innovation may be changing the face of diabetes forever.
